Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Feb 15, 2022; 14(2): 498-510
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.498
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.498
Figure 1 Schematic diagram of the regulatory mechanisms involved in the effects of alpha-L-fucosidase-1 on malignant tumor invasion and metastasis.
MMP: Matrix metalloproteinase; FUCA-1: Alpha-L-fucosidase-1; EGFR: Epidermal growth factor receptor.
Figure 2 The inclusion and exclusion criteria for screening 119 patients from Sun Yat-Sen University Cancer Center who underwent esophagectomy for esophageal squamous cell carcinoma.
EC: Esophageal carcinoma; ESCC: Esophageal squamous cell carcinoma; SCC: Squamous cell carcinoma.
Figure 3 Immunohistochemical staining for alpha-L-fucosidase-1 and matrix metalloproteinase 9 in esophageal squamous cell carci noma.
A: Stage IA esophageal squamous cell carcinoma (ESCC) with negative expression of alpha-L-fucosidase-1 (FUCA1) (total score, 0); B: Stage IIB ESCC with low expression of FUCA1 (total score, 2); C: Stage IIB ESCC with high expression of FUCA1 (total score, 12); D: Stage IB ESCC with negative expression of matrix metalloproteinase 9 (MMP-9) (total score, 0); E: Stage IB ESCC with low expression of MMP-9 (total score, 3); F: Stage IIIA ESCC with high expression of MMP-9 (total score, 12). Original magnification: 100 ×; scale bar: 100 μm.
Figure 4 Correlation analysis.
A: Positive lymph node metastasis (N+) is associated with a high alpha-L-fucosidase-1 (FUCA1) total score; B: Low FUCA1 expression is associated with a low matrix metalloproteinase 9 total score. FUCA1: Alpha-L-fucosidase-1.
Figure 5 Kaplan-Meier curves of overall survival in the Sun Yat-Sen University Cancer Center cohort.
A: Lymphatic invasion (N0/N+); B: Pathological tumor-node-metastasis stage (I-II/III); C: Alpha-L-fucosidase-1 expression (low/high); D: Matrix metalloproteinase 9 expression (low/high). MMP-9: Matrix metalloproteinase 9; FUCA-1: Alpha-L-fucosidase-1.
Figure 6 Kaplan-Meier curves of overall survival in The Cancer Genome Atlas database.
A: Alpha-L-fucosidase-1 expression (low/high); B: Matrix metalloproteinase 9 expression (low/high). MMP-9: Matrix metalloproteinase 9; FUCA-1: Alpha-L-fucosidase-1.
- Citation: Yu XY, Lin SC, Zhang MQ, Guo XT, Ma K, Wang LX, Huang WT, Wang Z, Yu X, Wang CG, Zhang LJ, Yu ZT. Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma. World J Gastrointest Oncol 2022; 14(2): 498-510
- URL: https://www.wjgnet.com/1948-5204/full/v14/i2/498.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i2.498